cgp 12177 and mirabegron

cgp 12177 has been researched along with mirabegron in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maruyama, T; Matsui, T; Miyata, K; Nagase, I; Sasamata, M; Sato, S; Takasu, T; Uchida, H; Ukai, M; Yamaguchi, O1
Alewijnse, AE; Michel, MC; Vrydag, W1

Other Studies

2 other study(ies) available for cgp 12177 and mirabegron

ArticleYear
Effect of (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 321, Issue:2

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Animals; Carbachol; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Humans; Isoproterenol; Muscle Contraction; Propanolamines; Thiazoles; Urinary Bladder

2007
Do gene polymorphisms alone or in combination affect the function of human beta3-adrenoceptors?
    British journal of pharmacology, 2009, Volume: 156, Issue:1

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Binding, Competitive; Biphenyl Compounds; Cell Line; Cyclic AMP; Humans; Isoproterenol; Mutagenesis, Site-Directed; Norepinephrine; Phenethylamines; Polymorphism, Single Nucleotide; Propanolamines; Radioligand Assay; Receptors, Adrenergic, beta-3; Thiazoles; Transfection

2009